You are viewing the site in preview mode

Skip to main content

Table 1 Basic characteristics and intervention results among men and women

From: Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism

  Men (n = 85) Women (n = 70) P value
Group, n (%)    0.220
 LSI 28 (32.94%) 25 (35.71%)  
 PGZ + LSI 22 (25.88%) 25 (35.71%)  
 BBR + LSI 35 (41.18%) 20 (28.57%)  
Age (age) 49.62 ± 10.81 53.47 ± 7.68 0.013
Smoking, n (%) 23 (27.06%) 2 (2.86%) < 0.001
Drinking, n (%) 25 (29.41%) 1 (1.43%) < 0.001
Glucose metabolism    0.643
 IGR, n (%) 42 (49.41%) 37 (52.86%)  
 T2DM, n (%) 43 (50.59%) 33 (47.14%)
Treatment adherence (%) 100 (15–100) 100 (32–100) 0.161
Baseline BMI (kg/m2) 28.0 ± 3.5 27.4 ± 4.0 0.301
Final BMI (kg/m2) 27.0 ± 3.1 26.5 ± 4.1 0.466
BMI changes (kg/m2) − 1.1 ± 1.1a − 0.9 ± 1.1a 0.270
Baseline LFC (%) 33.02 ± 13.70 36.01 ± 16.21 0.215
Final LFC (%) 19.65 ± 12.65 21.76 ± 15.79 0.357
Absolute changes of LFC (%) − 13.35 ± 15.41a − 14.27 ± 15.58a 0.714
 LSI (n = 53) − 12.64 ± 17.78a − 8.76 ± 13.49a 0.379
 PGZ + LSI (n = 47) − 9.95 ± 15.18a − 15.24 ± 14.54a 0.229
 BBR + LSI (n = 55) − 16.06 ± 13.35a − 19.95 ± 17.59a 0.359
  1. Data are given as means ± SD or median (Min-Max) for continuous variables and percentages for categorical variables. Absolute changes of LFC (%), the absolute changes separately in three groups or three groups combined. P value calculated by unpaired Student’s t test or Mann-Whitney U test for quantitative variables, and χ2 test or Fisher’s exact test for qualitative variables, differences between women and men
  2. IGR impaired glucose regulation, T2DM type 2 diabetes, BMI body mass index, LSI lifestyle intervention, PGZ pioglitazone, BBR berberine, LFC liver fat content
  3. aCalculated by paired t test, differences between before and after intervention